(Total Views: 409)
Posted On: 08/31/2022 10:10:56 AM
Post# of 68

$BCRX News Article - FDA Grants Orphan Drug Designation for BioCryst's ALK-2 Inhibitor, BCX9250, for the Treatment of Fibrodysplasia Ossificans Progressiva https://marketwirenews.com/news-releases/fda-...75245.html


My Twitter: WhyteStocks